Clinical trials recruiting for Other Solid Tumors
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ABO2102 | 1 |
| Binimetinib | 1 |
| Crizotinib | 1 |
| DXC008 | 1 |
| IDE196 | 1 |
| NT-175 | 1 |
| Toripalimab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| New York | 2 |
| North Carolina | 2 |
| Pennsylvania | 2 |
| Tennessee | 2 |
| Texas | 2 |
| Arizona | 1 |
| Colorado | 1 |
| Florida | 1 |
| Iowa | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors
- A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors
Related conditions
Trials recruiting for Other Solid Tumors often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Other Solid Tumors trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.